MEI Pharma Inc (LTS:0JW9)
$ 3.102 -0.0388 (-1.24%) Market Cap: 21.05 Mil Enterprise Value: -17.29 Mil PE Ratio: 1.16 PB Ratio: 0.62 GF Score: 54/100

MEI Pharma Inc Post-ASCO Virtual Scientific Program Investor and Analyst Presentation Transcript

Jun 02, 2020 / 12:00PM GMT
Release Date Price: $80.2 (+6.65%)

Jun 02, 2020 / 12:00PM GMT
Presentation
Jun 02, 2020 / 12:00PM GMT

=====================
Corporate Participants
=====================
* Daniel P. Gold
MEI Pharma, Inc. - President, CEO & Director
* Richard G. Ghalie
MEI Pharma, Inc. - SVP of Clinical Development

=====================
Conference Call Participants
=====================
* Adam Gerald Evertts
LifeSci Capital, LLC, Research Division - Senior Research Analyst
* I-Eh Jen
Laidlaw & Company (UK) Ltd., Research Division - MD of Healthcare Research & Senior Biotechnology Analyst
* James William Birchenough
Wells Fargo Securities, LLC, Research Division - MD and Senior Biotechnology Analyst
* Matthew David Cross
JonesTrading Institutional Services, LLC, Research Division - Research Analyst
* Srikripa Devarakonda
SunTrust Robinson Humphrey, Inc., Research Division - Associate
* Stephen Douglas Willey
Stifel, Nicolaus & Company, Incorporated, Research Division - Director
* Thomas Eugene Shrader
BTIG,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot